Senate blocks bid to end reverse payment deals
The Senate has blocked an amendment that would have given the Federal Trade Commission power to intervene in so-called reverse payment agreements
The House of Representatives approved legislation in June that would stop settlements between brand name and generic pharmaceutical companies as part of the Supplemental Appropriations Act of 2010 (the war bill).
At the time, FTC commissioner Jon Leibowitz praised the...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.